Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Accolade Community
NasdaqGS:ACCD Community
1
Narratives
written by author
0
Comments
on narratives written by author
7
Fair Values set
on narratives written by author
Create a narrative
Accolade
Popular
Undervalued
Overvalued
Community Investing Ideas
Accolade
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Expanding Health Plan Partnerships Will Unlock Integrated Healthcare Solutions
Key Takeaways Accolade’s partnership expansions and bundled solutions strategy aim to enhance revenue growth and elevate net margins. Streamlined operations and a large partner ecosystem are expected to improve client satisfaction and boost earnings.
View narrative
US$7.03
FV
0.1% undervalued
intrinsic discount
11.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
11 days ago
author updated this narrative
Your Valuation for
ACCD
ACCD
Accolade
Your Fair Value
US$
Current Price
US$7.02
15.1% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-464m
762m
2015
2018
2021
2024
2025
2027
2030
Revenue US$762.1m
Earnings US$55.6m
Advanced
Set Fair Value